BHCM
SGEN

Brevan Howard Capital Management’s Seagen Inc. Common Stock SGEN Stock Holding History

Brevan Howard Capital Management’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-27,445
Closed -$5.82M – 1120
2023
Q3 		$5.82M Buy
+27,445
New +$5.48M 0.08% 37

Other funds holding SGEN

SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FBC
Fairfield, Bush & Co Darien, Connecticut $203M AUM 38.37% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
SAG
Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Brevan Howard Capital Management's SGEN Position: Q4 2023 in Review

Brevan Howard Capital Management sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 27,445 shares — an estimated $5.82M sold.

Brevan Howard Capital Management first reported a position in SGEN in Q3 2023 and held it in 1 quarter. The position peaked at $5.82M in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

  • Brevan Howard Capital Management reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Brevan Howard Capital Management sold 27,445 Seagen Inc. Common Stock shares in Q4 2023, an estimated $5.82M.
  • Brevan Howard Capital Management first reported a position in Seagen Inc. Common Stock in Q3 2023 and held it in 1 quarter.
  • Brevan Howard Capital Management's Seagen Inc. Common Stock position peaked at $5.82M in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Brevan Howard Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.